Objectives: The aim of this study was to investigate, using quantitative sensory testing (QST) parameters and the painDETECT (PD-Q) screening questionnaire, the presence of neuropathic pain (NeP) in patients with unilateral painful cervical radiculopathy (CxRAD) and in patients with unilateral nonspecific neck-arm pain associated with heightened nerve mechanosensitivity (NSNAP).
N erve-related neck-arm pain disorders are heterogenous with clinical signs and symptoms and pattern of pain and sensory abnormalities varying widely between individuals. Although a neuropathic mechanism is commonly implied in disorders such as painful cervical radiculopathy (CxRAD), 1 patients are likely to present with a mix of nociceptive and neuropathic pain (NeP), more commonly referred to as a mixed pain syndrome. [2] [3] [4] [5] [6] [7] Both NeP and mixed pain syndromes can be intense forms of pain, and patients with these disorders are characterized by impaired physical and mental quality of life and a substantial level of disability, leading to increased health care costs compared with patients with nociceptive pain. 5, 6, 8 Characterization of these patients with respect to the "pain mix," and the possible dominance of 1 pain type in mixed pain syndromes is of therapeutic relevance, 9 as NeP in particular requires targeted management.
This study investigated 2 samples of patients with nerve-related neck-arm pain: patients with painful CxRAD and patients with nonspecific neck-arm pain (no clinical signs of radiculopathy) associated with heightened nerve mechanosensitivity (NSNAP). Heightened nerve mechanosensitivity is defined as pain in response to upper limb movement that causes nerve elongation. 10 This condition can present as a discrete disorder without any signs of nerve damage such as sensory or motor loss. 10, 11 Patients with CxRAD and NSNAP may demonstrate similar pain characteristics such as pain with or without negative/positive sensory symptoms, however, the mix of NeP and nociceptive pain may vary.
Quantitative sensory testing (QST) has been recommended for accurate sensory profiling in the assessment of patients with NeP 12 and side-to-side comparison of QST data within patient groups is recommended, 13, 14 as patients may present with subtle sensory alterations not identifiable by comparison with reference data. To date, 1 study investigated sensory abnormalities in patients with CxRAD, 15 however, QST measurements were not taken from the patient's maximal pain area, as is required for the assessment of NeP components. 12, 16 While we have previously investigated somatosensory profiles using QST in healthy controls and patient groups including CxRAD, NSNAP and fibromyalgia, 17 we did not specifically investigate the presence of NeP components as conducted in the current study.
Further, the use of NeP screening tools for identification of NeP components has been recommended. 12 The painDETECT (PD-Q), 18 a validated self-reported NeP screening tool, has increasingly been used for the identification of NeP in patients with low back and leg pain, [18] [19] [20] [21] however, its usefulness in the screening of NeP in patients with neck-arm pain has not been reported.
The purpose of this study was to investigate, using QST and the PD-Q, the presence of NeP components in patients with CxRAD and in patients with NSNAP. We hypothesized that: 1. For patients with CxRAD, there would be a significant side-to-side difference in QST parameters between the symptomatic and asymptomatic side. 2. For patients with NSNAP, there would be no significant side-to-side difference in QST parameters between the symptomatic and asymptomatic side. 3. There would be no difference in the PD-Q score between patients with CxRAD and patients with NSNAP.
MATERIALS AND METHODS

Patients
Patients were recruited as part of another concurrent study. 17 For inclusion into the study, all patients were required to fulfill the inclusion criteria of unilateral neck pain and arm pain/paresthesia in a C6/7 distribution, symptom duration of 3 to 18 months, and current pain intensity Z2 on a visual analog scale (VAS). Patients with CxRAD were required to demonstrate signs of either C6 or C7 nerve root dysfunction with neurological deficits consistent with the affected nerve root level and with compressive radiculopathy (either absent or diminished reflexes and/or myotomal weakness and dermatomal sensory deficits of light touch and/or vibration sense). In addition, patients were required to have a demonstrable clinically relevant abnormality on imaging studies 16, 22 that indicated compromise of the exiting nerve root at the relevant spinal level. Inclusion criteria for patients with NSNAP were no clinical signs of radiculopathy and evidence of increased peripheral nerve sensitivity to mechanical stimuli, 10 including pain in response to a nerve provocation test in the upper limb (NPT MEDIAN ). 10 Exclusion criteria for both groups were: evidence of a metabolic or a medical disease; other neurological or psychiatric disease; a history of cardiovascular disease; and an insufficient level of English. Patients had to be able to understand the PD-Q questions and independently complete the PD-Q. Specifically, patients had to be able to understand the instructions and requirements for the QST procedures and be able to give a reliable response that did not depend on translation. Patients were not screened for the presence of depression or anxiety.
Before participation, all patients were examined by a highly qualified Musculoskeletal Physiotherapist (B.T., Master qualification) who had extensive clinical experience within a tertiary pain medicine unit in triaging patients with suspected nerve lesions and associated NeP to ascertain they met the inclusion criteria. The assessment included the patient's history, pain drawings, pain description for their neck and arm pain and pain behaviors, musculoskeletal and neurological examination, and review of reports of diagnostic tests (imaging and nerve conduction studies). The diagnostic classification of both participating groups was verified by a Fellowship-trained spinal Neurosurgeon (G.L.) and a Fellowship-qualified (Fellow of the Australian College of Physiotherapists) Specialist in Musculoskeletal Physiotherapy (T.H.), both of whom were blinded to the clinician's patient classification. Each Fellow independently reviewed the patients' notes and the results of any medical investigations. Only patients whose clinical presentation was confirmed by all 3 examiners were included in the data analyses ( Fig. 1 ).
Patients were recruited from private clinics and physiotherapy, pain management, and neurosurgery departments at 5 local metropolitan hospitals in Perth, Western Australia, and from the local community through radio and newspaper advertising ( Fig. 1 ). All referrals of patients with neck/upper limb symptoms to the neurosurgery triage clinic received between September 2007 and November 2010 were reviewed by the investigator (B.T.). Patients in whom the referral indicated the possible presence of a unilateral nerve lesion/disease were selected and clinically examined. The study protocol and recruitment procedures were approved by the local Ethics Committees of all participating institutions and adhered to the ethical guidelines of the Declaration of Helsinki. All patients were asked to sign an informed consent form before participation.
Questionnaire
A battery of questionnaires was used to clinically characterize the patient groups and to incorporate the multidimensional aspects of pain as proposed by the IMMPACT guidelines. 23 This battery was administered immediately before the QST. The instructions given on the questionnaires were the instructions consistent with the standardized instruments. All patients completed the short form-36 health questionnaire (SF-36v2) 24 to assess healthrelated quality of life. The Hospital Anxiety and Depression Scale 25 was used to screen for anxiety and depression, with 2 outcome scores generated, each with a maximum score of 21 for each parameter. Scores of r10 for each are considered within normal range. Sleep quality over the last week was recorded on a 100 cm VAS with the endpoints 0 cm (good sleep) and 10 cm (bad sleep). 26 In addition, to assess fear avoidance behaviors, patients completed the Tampa Scale of Kinesiophobia (TSK). 27 This questionnaire contains 17 items that relate to fear of movement and fear of (re) injury. A score of Z40 is considered to indicate significant kinesiophobia. 28 The Neck Disability Index (NDI) 29 was used to assess the level of patient disability. It is a well-validated 10-item questionnaire. 30, 31 Scores of <4 indicate no disability, 5 to 14 mild disability, 15 to 25 moderate disability, 25 to 34 severe disability, and > 35 complete disability. 29 The PD-Q 18 consists of 1 descriptor relating to temporal and 1 to spatial pain characteristics and of 7 weighted sensory descriptors. These sensory descriptors relate to the main pain area that a person records on the body chart of PD-Q. 18 The lowest weight for each descriptor is 0, indicating that the person does not experience the relevant sensation, and the highest weight is 5, indicating the sensation is felt very strongly. PD-Q classifies patients into 3 groups, defined by Freynhagen et al 18 as follows: the result is negative = a NeP component is unlikely (score 0 to 12), the result is unclear = the result is ambiguous, however, a NeP component can be present (score 13 to 18), or the result is positive = a NeP is likely (score 19 to 38). The strongest and average pain intensity over the last 4 weeks was recorded on a numeric rating scale (0 = no pain, 10 = maximum pain) as part of the PD-Q. 18 Patients were not given any specific instructions on how to complete the PD-Q other than the instructions given on the questionnaire. using the same equipment and standardized instructions as outlined by Rolke et al. 14, 32 The test battery comprised the following assessments: cold and warm detection thresholds (CDT, WDT); the number of paradoxical heat sensations (PHS) during the procedure of alternating warm and cold stimuli [thermal sensory limen (TSL)]; cold and heat pain thresholds (CPT, HPT); mechanical detection threshold (MDT); mechanical pain threshold (MPT); stimulusresponse functions: mechanical pain sensitivity (MPS) and dynamic mechanical allodynia (DMA); wind-up ratio (WUR); vibration detection threshold (VDT); and pressure pain threshold (PPT).
QST was performed over the maximal pain area, as indicated by the patients and the corresponding contralateral mirror side. In patients with CxRAD, additional testing was conducted in the exact dermatomal area of sensory loss as determined during clinical examination, and for patients with NSNAP in the area of distal paresthesia or pain, plus in the contralateral side for both groups. Although the QST in the dermatome does not give information about the presence of NeP components, 16 it does assist to further characterize each patient group and to detect possible sensory alterations that may be indicative of a nerve root lesion. Testing was conducted by 1 investigator (B.T.) in a laboratory with a constant room temperature. The investigator was blinded to the results of the PD-Q as the questionnaire was scored after the QST testing. As the clinical examination of patients and QST testing were not performed on the same day, the key inclusion criteria for each group (for CxRAD: signs of nerve root dysfunction; for NSNAP: absence of nerve root dysfunction and presence of heightened nerve mechanosensitivity) were reassessed before QST. Patients were asked not to take any analgesics on the day of testing. A sample size calculation, based on QST data by Rolke et al, 14 estimated that a sample of 25 in each patient group was needed to detect clinically significant differences between the symptomatic and asymptomatic arm.
NPT MEDIAN
The NPT MEDIAN was performed after the QST as described previously. 11 The range of elbow extension was measured with an electrogoniometer (SG110; Biometrics Ltd, United Kingdom). The patient was asked to press an external trigger at the first onset of pain or at the increase of their resting pain (P1) if present, and at a second time point when the patient reached their pain tolerance (P2) for this movement. Elbow extension was performed to the end of joint range or to P2, whichever occurred first. The NPT MEDIAN was performed 3 times on each side and the mean value of 3 recordings of P1 and P2 was used for analysis. Patients who did not report consistently an onset of P1 or P2 in all 3 trials (ie, they reported an onset in only 1 or 2 trials) were excluded from the analysis (P1 asymptomatic side, n = 3). Four patients with CxRAD could not be tested due to high pain levels and the associated potential for exacerbation of their condition.
Statistical Analysis
SPSS version 17 was used for all analyses. All data were analyzed for their distribution properties (the Shapiro-Wilk test). An independent t test was used to compare symptom duration, pain intensity, sleep quality, the NDI, TSK, and PD-Q scores between patient groups. Anxiety and depression scores and the physical and mental component summary scores of the SF-36 were compared using the Mann-Whitney U test.
The QST variables HPT and VDT were normally distributed. All other QST data were normally distributed in log-space and were log-transformed before statistical analysis. 32 Within each group, QST data were compared between sides using a paired t test. For patients with CxRAD, a side-to-side comparison was also performed for 2 subgroups, based on imaging results: (1) patients with nerve root compression due to a disk protrusion/herniation (n = 14) and (2) patients with nerve root compression due to osteophytic stenosis (n = 7). Responses to the NPT MEDIAN were compared using the Wilcoxon signedrank test, as data were not normally distributed. Significance was accepted at P < 0.05 for all analyses.
RESULTS
Patient Characteristics
Twenty-three patients with painful C6 or C7 CxRAD (8 females; mean age, 46.3 ± 9.6 y) and 8 patients with NSNAP following a C6/C7 dermatomal distribution (7 females; mean age, 45.1 ± 14.9 y) participated in the study. Eleven patients presented with a C6 radiculopathy and 12 patients with a C7 radiculopathy. Their maximal pain areas were as follows: upper trapezius muscle (n = 4); paravertebral cervical spine (n = 2); paravertebral thoracic spine (n = 7); above and below spine scapula (n = 2); upper arm (n = 5); forearm (n = 2); and just above the elbow (n = 1). All patients with CxRAD had undergone medical imaging (computed tomography [CT] [n = 1]) and magnetic resonance imaging (n = 22). On the basis of the imaging findings, 7 patients demonstrated nerve root compression due to osteophytic stenosis, 2 patients due to a disk/ osteophytic complex, and 14 patients due to a disk protrusion/herniation. One patient with NSNAP presented with pain in a C6 dermatomal distribution and 7 patients with pain in a C7 dermatomal distribution. Six patients reported the upper trapezius muscle as their maximal pain area and 2 patients the paravertebral thoracic spine. Only 2 patients with NSNAP had medical imaging (CT) performed of the cervical spine. In these 2 patients, CT did not demonstrate any abnormality indicating compromise of a nerve root at the relevant spinal level. Table 1 presents demographic data of all patients. The independent t test showed no significant differences between groups in terms of age, symptom duration, pain intensities, fear avoidance behavior, and scores on the NDI. NDI scores reflected moderate disability for patients with CxRAD and mild disability for patients with NSNAP. There were no significant differences between groups physical and mental components of the SF-36 and anxiety and depression scores (Mann-Whitney U Test). The anxiety scores were within the normal range in over 75% of patients and the depression scores in over 91% of patients. Patients with CxRAD had a significantly higher score on the PD-Q compared with patients with NSNAP (independent t test: P = 0.038). Seven patients (30%) with CxRAD reported a score of Z19, indicating the "likely" presence of NeP and 1 patient (12.5%) with NSNAP scored Z19. A larger proportion of patients with CxRAD were on pain medication compared with the group with NSNAP. The patients' self-reported pain descriptors for their neck and arm pain obtained during the clinical examination are documented in Table 2 . Both groups demonstrated clinical signs of heightened nerve mechanosensitivity in the symptomatic arm, indicated by a significant side-to-side difference in the range of motion of elbow extension deficit at the onset of P1 (P < 0.03) and P2 (P < 0.013) between arms ( Fig. 2) (Wilcoxon signed-rank test). In both groups, the pain onsets occurred much earlier in the range in the symptomatic arm compared with the asymptomatic arm.
Side-to-Side Comparison in Patients With CxRAD
For patients with CxRAD, in the maximal pain area vibration and mechanical detection sense were significantly reduced on the symptomatic side compared with the asymptomatic side (paired t test; VDT: P = 0.003; MDT: P = 0.021) ( Table 3) . Side-to-side comparisons of all other QST parameters in the maximal pain area were not significant. In the dermatome, there was a loss of function on the symptomatic side in cold detection (CDT: P = 0.021), mechanical detection (MDT: P < 0.001), vibration detection (VDT: P = 0.001), and pressure pain sensitivity (PPT: P = 0.005) ( Table 4 ). There were no side-to-side differences in any other QST parameters. Reports of DMA and PHS were infrequent. One patient with CxRAD demonstrated DMA bilaterally in the maximal pain area and on the symptomatic side in the dermatome. PHS was reported by 1 patient once in the maximal pain area on the symptomatic side, and by a different patient once on the asymptomatic side. Two patients reported PHS once on the asymptomatic side of the dermatome. Individual QST data are presented in Table 5 (Supplemental Digital Content 1, http://links. lww.com/CJP/A53). One patient seemed to present with only 1 sensory alteration in the maximal pain area on the symptomatic side. All other patients seemed to demonstrate 2 or more sensory alterations on the symptomatic side. Eleven patients demonstrated cold hyperalgesia (Z151C) 33 on the symptomatic side, and in 5 of these patients cold hyperalgesia occurred bilaterally. Some patients presented with reduced pressure sensitivity in their main pain area, whereas others presented with increased pressure sensitivity.
Patients with nerve root compression due to osteophytic stenosis (n = 7) demonstrated a loss of function on the symptomatic side of the maximal pain area in warm detection (WDT: P = 0.034), TSL (P = 0.010), vibration detection (VDT: P = 0.007), and pressure sensitivity (PPT: P = 0.029), and a loss of function in the symptomatic dermatome in cold detection (CDT: P = 0.007), mechanical (MDT: P = 0.003), and vibration detection (VDT: P = 0.032) compared with the asymptomatic side (paired t test). Patients with nerve root compression due to a disk protrusion/herniation (n = 14) demonstrated reduced mechanical detection sense on the symptomatic side in the maximal pain area (MDT: P = 0.013) and reduced mechanical and vibration sense and pressure sensitivity in the symptomatic dermatome (MDT: P < 0.001; VDT: P = 0.004; PPT: P = 0.006) (paired t test).
Side-to-Side Comparison in Patients With NSNAP
In patients with NSNAP, in the maximal pain area, there was no side-to-side difference in any QST parameter (Table 3 ; paired t test). In the dermatome, the side-to-side comparison demonstrated a significant loss of function on the symptomatic side in WDT (P = 0.030) ( Table 4) . No other side-to-side comparisons were statistically different. No patient with NSNAP demonstrated DMA in any body region. PHS was reported by 1 patient twice on the symptomatic side in the maximal pain area. Individual QST data are presented in Table 6 (Supplemental Digital Content 2, http://links.lww.com/CJP/A54). Three patients demonstrated more than 1 sensory alteration in their maximal pain area on the symptomatic side (patient 3, 4, and 5). Three patients (patients 1, 4, and 8) demonstrated bilateral cold hyperalgesia.
DISCUSSION
This study investigated differences in QST parameters between symptomatic and asymptomatic sides and the presence of NeP components in patients with painful CxRAD and in patients with NSNAP, using QST and the PD-Q. The patient groups demonstrated similar clinical profiles, as indicated by their psychometric data, but the dominant pain type differed between groups. In patients with CxRAD, QST findings demonstrated a significant loss of function mediated by non-nociceptive sensory fibers in the painful innervation territory of the affected nerve root on the symptomatic side compared with the asymptomatic side, findings consistent with the characteristics of NeP. 12 The PD-Q identified 30% of patients with CxRAD demonstrating the likely presence of NeP. In patients with NSNAP, the absence of significant side-to-side differences in any QST parameters in the maximal pain area and the results of PD-Q suggest that NeP components were unlikely.
Patients with CxRAD demonstrated significant sideto-side differences in mechanical and vibration detection in their maximal pain area, the symptomatic side being less sensitive to the stimuli than the control side. The hypoesthesia on the symptomatic side is consistent with a loss of function due to nerve root damage and with the presence of NeP, 16 and consistent with both findings in patients with peripheral nerve injury [34] [35] [36] and for patients with segmental postsurgical NeP. 34 Furthermore, almost all patients with CxRAD demonstrated 2 or more sensory alterations in their maximal pain area. It has been reported that the frequency of sensory aberrations tends to increase with the likelihood of the presence of NeP. 37 The significant loss in the affected dermatome of cold, mechanical, and vibration detection and pressure sensitivity, also support the presence of a nerve root lesion. The loss of cold detection is comparable with findings in affected dermatomes of patients with cervical 15 and lumbar radiculopathy [38] [39] [40] [41] [42] and the loss of mechanical and vibration detection has also been reported in the affected dermatomes of patients with lumbar radiculopathy. 38 QST data in CxRAD is scarce, with 1 study profiling this patient group, 15 and findings demonstrated bilateral cold and pressure pain hypersensitivity in the cervical spine area. Comparison of our data to these findings is, however, limited as the majority of our patients did not have their maximal pain area in the cervical spine; furthermore the cervical spine area tested in the Chien et al study 15 did not necessarily reflect the maximal pain area of these patients. On a group level, our patients with CxRAD did not demonstrate cold hypersensitivity compared with the asymptomatic side; however, individual QST data revealed that 48% of our patients presented with cold hyperalgesia. Cold hyperalgesia is a common sequel of peripheral nerve injury, 35, [43] [44] [45] but it can also occur in the absence of nerve damage and pain, as documented in patients with painless peripheral nerve injuries 35, 44 and in patients with depression without pain. 46 Bilateral cold hyperalgesia, as seen in some of our patients with CxRAD, was also observed in individuals with painful and painless peripheral nerve injuries. 44 Mechanisms underlying cold hypersensitivity are still not fully understood and likely include both central [47] [48] [49] and peripheral nervous system mechanisms. [50] [51] [52] In contrast to patients with, for example, peripheral nerve injury demonstrating mechanical hyperalgesia, 44, 53, 54 such a positive sensory sign was not a dominant feature in our patients with CxRAD. Increased pressure sensitivity was observed in some individuals with CxRAD, however, others demonstrated reduced pressure sensitivity. Similar pressure pain dichotomy has also been documented in individuals with peripheral nerve injury. 44 The variances between individual patients indicates the likely presence of subgroups with differing somatosensory profiles within our cohort, similar to somatosensory profiles reported for patients with lumbar radiculopathy 55 and for patients with peripheral NeP. 53, 54 Somatosensory heterogeneity within a clinical disorder may account for differing individual responses to pharmaceutical interventions, as seen in clinical trials of patients with lumbar and cervical radiculopathies. 56, 57 Furthermore, we found differing sensory profiles between groups depending on the cervical imaging findings. The group with mechanical nerve root compression due to osteophytic stenosis demonstrated a loss of small and large sensory fiber function in the symptomatic maximal pain area, whereas a loss of only large sensory fiber function occurred in the disk herniation group. It is unclear why these differences in sensory phenotypes occurred, and studies with larger sample sizes are required to further attest these findings. Our data highlight the need for individual patient examination including clinical history as well as clinical examination, screening for NeP, and the presence of psychological factors, and imaging if appropriate. This approach is required to make a more fully informed clinical decision regarding the sensory profile and how that may link with targeted management. For example, a patient characterized by increased pain sensitivity may require specific behavioral and cognitive management, possibly different pain medication and appropriate physical intervention such as pacing strategies compared with a patient without heightened pain sensitivity.
According to the recently proposed diagnostic grading system of certainty for the presence of NeP, 16 on a group level our cohort with CxRAD demonstrated definite NeP, however, this does not exclude the simultaneous presence of nociceptive pain. Other structures (eg, joints, disks, and muscles) are likely involved in contributing to nociceptive input and potentially impacting the total "pain experience." Fourteen patients (61%) indicated the neck/trapezius/ scapula/thoracic area as their main area of pain which correlates with specific cervical nerve root pain distributions, 58 and is also a common area for musculoskeletal pain and referred somatic pain. 59 Coexisting musculoskeletal disorders are common in patients with suspected CxRAD 60 and nociceptive pain may be located in the same area as the innervation territory of the affected nerve structure. This consideration might complicate the interpretation of sensory aberrations, as sensory changes can be present in non-NeP conditions. [61] [62] [63] [64] In our current study, the likely presence of mixed pain 3 is reflected in the PD-Q scores and the self-volunteered pain descriptors. Patients used self-reported pain descriptors commonly identified for NeP, 65 some of these matching the descriptors used in PD-Q, however, patients also used descriptors commonly identified for nociceptive pain. 66 The fact that 30% of our radiculopathy cohort reported a score of Z19, and 65% reported a score of Z16, may suggest that on a theoretical continuum between "dominantly nociceptive" and "dominantly neuropathic" pain, 67 some of these individual sensory profiles were characterized dominantly by NeP components compared with nociceptive pain.
Patients with NSNAP did not demonstrate any side differences in QST parameters in their maximal pain area. Hence based on the pain distribution and history, this group would be classified as having "possible" NeP. 16 However, some individuals did present with sensory alterations in their maximal pain area (bilateral cold hyperalgesia and apparent reduced vibration sense). It stands debatable if these sensory aberrations are indicative of NeP, as such sensory changes have also been reported in non-NeP conditions. [61] [62] [63] [64] Hence clinical judgment based on the findings of a comprehensive clinical examination, including the assessment of neural and musculoskeletal structures and other organ systems, is crucial for the determination of underlying pain types.
With the exception of reduced warm detection in the symptomatic arm, where the difference between sides was <11C and of doubtful clinical significance, we did not find any side differences for QST parameters in the dermatome in patients with NSNAP. The interpretation of what entails a clinically significant difference for thermal detection thresholds is inconsistent. 14, 36, 44, 68 On the basis of clinical judgment, some authors consider a side difference of Z± 11C as pathologic, 36 others argue a side difference of ±11C is within normal range. 14, 68 More normative data from various body regions are required to attest these statements.
The QST findings in our patients with NSNAP do not suggest the presence of NeP components and on the whole this is in accordance with the PD-Q score in this group, with the exception of 1 individual who scored >19. This person may have been an outlier with a maximum score (5) for the presence of a burning sensation and tingling, and a high score (4) for the presence of numbness in her pain area. The weighing of the pain descriptor item of PD-Q may lead to skewing of the final score of PD-Q toward the presence of NeP. Apart from the descriptors for the presence of paresthesia being used by all patients, a minority of patients used self-reported pain descriptors common to NeP.
The main characteristic for this group was the side-toside difference in pain response to the NPT MEDIAN , consistent with a heightened pain response in the symptomatic arm. Our results suggest that the clinical presentation of heightened nerve mechanosensitivity as a discrete disorder should not equate with the presence of a NeP component. This group with NSNAP did not meet the new definition of NeP, that is, "pain caused by a lesion or disease of the somatosensory nervous system," 69 as the combination of clinical examination findings, QST data, and available diagnostic tests did not provide evidence for the presence of a nerve lesion. Heightened nerve mechanosensitivity can coexist with nerve lesions and NeP, as demonstrated in our patients with CxRAD and another patient group. 15 In fact, heightened nerve mechanosensitivity in the lower limb, as identified by the straight leg raise test, was reported to be part of a cluster of physical examination discriminative indicators for NeP in lumbar radiculopathy. 70 However, the role of heightened nerve mechanosensitivity as discriminative factor for NeP in patients with CxRAD has not yet been determined.
The PD-Q 18 was specifically designed to identify NeP components in patients with low back pain with and without referred pain, and therefore it was anticipated that the questionnaire could be transferable to patients with neck-arm pain. However, the PD-Q 18 identified only 30% of participants with CxRAD as having NeP. This seemingly lowered capability of PD-Q to identify NeP compared with the sensitivity of 85% in the original validation study 18 may be related to a mismatch between the pain descriptors reported by the patients and the pain descriptors included in PD-Q. For example, sensitivity to light touch was not a dominant feature in our radiculopathy cohort, consistent with findings in patients with lumbar radiculopathy, 55 and similarly cold and pressure sensitivity and burning pain were only present in some individuals. Using PD-Q, Mahn et al 55 identified 1 subgroup of patients with radicular leg pain presenting with only 1 dominant sensory descriptor contained in the PD-Q. 55 The PD-Q had been originally validated in a dichotomous patient sample (NeP/nociceptive pain) and patients with mixed pain presentations were excluded. 18 Splitting patients into 2 categories may limit the ability to generalize results to a mixed pain clinical population. It remains unclear if the discrepancy in performance of the PD-Q in our study and in the original validation study 18 relates to variations in patient cohorts, as specific patient characteristics were not reported in the original study. 18 Another possible explanation for the lowered sensitivity of PD-Q may be the weighing of the item descriptors. In a study of patients with spinal cord injuries, 71 cutoff levels for discriminating NeP were low in the weighted items of PD-Q and it was suggested that the intensity of the sensory descriptor may not be that important for discrimination, but simply its presence or absence. Summary of our findings suggest that the PD-Q may not be suitable for the identification of NeP in patients with CxRAD and mixed pain.
The strength of our study lies in the robust methods, including a complete examination (clinical and standardized QST) of patients with CxRAD and patients with NSNAP and using tight inclusion/exclusion criteria. Although the latter was chosen to ensure our groups were homogenous, the strict inclusion criteria brought with them the compromise of obtaining smaller sample sizes than anticipated and also limit the generalizability of our findings. The sample size of our group with NSNAP was modest and this might limit the power to demonstrate significant side-to-side differences. Despite extensive recruitment efforts over the period of 3 years, we were not able to recruit more patients fulfilling the criteria for NSNAP inclusion. On the basis of our recruitment strategy, and given the fact that many patients were recruited from a neurosurgery triage clinic, the prevalence of the discrete disorder of NSNAP would seem to be low. Only anecdotal data exist on the prevalence of this condition. A further limitation of the study lies in the nonblinding of the investigator performing the QST testing and future research would be strengthened by a design that incorporated blinding.
In conclusion, although patients with CxRAD and patients with NSNAP had commonalities in their clinical pain pattern and clinical profile, the dominant pain type differed between groups, as indicated by the specific QST profiles and associated responses to the PD-Q. NeP was more common in patients with CxRAD, whereas patients with NSNAP were characterized by predominantly nociceptive pain components. The variability of sensory profiles between individuals within 1 group highlights the importance of individual assessment for the identification of NeP components for patients with mixed pain syndromes. The PD-Q seemed unsuitable for the identification of NeP in our patients with CxRAD and should not be used as a surrogate for clinical examination. Our somatosensory profiles for these clinical groups may assist clinicians in targeting more specific management for these patients and reinforces the importance of skilled clinical examination in making clinical management decisions for patients with suspected NeP.
